webReport
A voyage of discovery through the Bayer world
Our webReport invites you on a voyage of discovery through the Bayer world. You will find up-to-date reports on innovative products, our social commitment and recent results of our research.
| Image: Focusing on expansion | Focusing on expansion Bayer plans to invest roughly EUR 100 million at its Brazilian sites through the end of 2009. The announced investment program will focus on Belford Roxo. » more |
| Image: Treasures from the past | Treasures from the past Carl Duisberg was unable to part with any of his notes, so what better idea than to found an archive? This is precisely what the first Bayer Managing Director did exactly 100 years ago. » more |
| Image: From birth-control pills to cancer therapies | From birth-control pills to cancer therapies The acquisition of Schering was the largest take-over in Bayer’s history. Under the name Bayer Schering Pharma AG, Germany*, the joint pharmaceutical company is now aiming to become one of the largest players on the world market. » more |
| Image: The Bayer Cross | The Bayer Cross This huge sign is an unmistakable landmark in the Leverkusen night sky. But the Bayer Cross is much more than just a large advertising sign. As a symbol it is the most important element in the company's image and a seal of quality worldwide for Bayer's services and products. » more |
*
The names "Bayer Schering Pharma" or "Schering" as used in this website always refer to Bayer Schering Pharma AG, Berlin, Germany, or its predecessor, Schering AG, Berlin, Germany, respectively.